New York, NY -- (SBWIRE) -- 12/06/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: FANNIE MAE PFD S (OTCBB:FNMAS), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Novavax, Inc (NASDAQ:NVAX), Newmont Mining Corp (NYSE:NEM)
FANNIE MAE PFD S (OTCBB:FNMAS) showed a volume of 1.16 million shares by the end of last trade whereas the average volume of the stock remained 1.76million shares. The stock opened the session at $7.90but then moved to $7.84. At that price, the stock showed a negative performance of -1.38%.
Will FNMAS Get Buyers Even After The Recent Rally? Find Out Here
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) opened the session at $1.51 and closed the session at $1.43. The stock showed a negative performance of 4.03% in previous trading session. Traded with volume of 5.00million shares in the prior session and the average volume of the stock remained 764,697.00 shares. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation). It is also engaged in proton exchange membrane (PEM)
Has BLDP Found The Bottom And Ready To Gain Momentum? Find Out Here
Novavax, Inc (NASDAQ:NVAX) opened the session at $4.00 and closed the session at $4.04. The stock showed a positive performance of 0.75% in previous trading session. Traded with volume of 5.64 million shares in the prior session and the average volume of the stock remained 3.71 million shares. The beta of the stock remained 2.41. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins. In July 2013, Novavax acquired approximately 97.4% of shares in Isconova AB.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
Newmont Mining Corp (NYSE:NEM) the stock decreased -2.85% and finished the session at $23.20. Traded with volume of 11.67 million shares in the prior session and the average volume of the stock remained 9.01 million shares. The beta of the stock remained 0.08. Newmont Mining Corporation is primarily a gold producer with operations and/or assets in the United States, Australia, Peru, Indonesia, Ghana, New Zealand and Mexico. As of December 31, 2012, Newmont had attributable and probable gold reserves of 99.2 million ounces and an aggregate land position of approximately 29,000 square miles (75,000 square kilometers). Newmont is also engaged in the production of copper, principally through Batu Hijau in Indonesia and Boddington in Australia. Its operating segments include North America,
Will NEM Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)